The roles of epidermal growth factor receptor (EGFR) inhibitors in the management of lung cancer

Summary: Targeting epidermal growth factor receptor (EGFR) is an important treatment option for non-small cell lung cancer (NSCLC).These targeted therapies have been studied extensively in NSCLC in first line and subsequent lines, including maintenance in empiric fashion or in patients with tumors h...

Full description

Bibliographic Details
Main Authors: Ashwaq Al Olayan, Hamad Al Hussaini, Abdul Rahman Jazieh
Format: Article
Language:English
Published: Elsevier 2012-12-01
Series:Journal of Infection and Public Health
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034112000986